DiscovertHEORetically SpeakingtHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies

tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies

Update: 2025-10-06
Share

Description

In this episode of tHEORetically Speaking, Paige McGarry interviews Aaron Berger, SVP & Head of Evidence Development Solutions at UBC discussing the evolution of direct-to-patient (DTP) study designs and how they are reshaping the landscape of clinical research.


Learn more here: https://healtheconomics.com/theoretically-speaking-rethinking-decentralization-in-direct-to-patient-studies/


Introducing Trial Insights—the essential tool for pharma researchers and biotech investors. 

Seamlessly track clinical trials in real-time, refine searches by key criteria, and receive timely notifications on important updates. With Trial Insights, ensure your research and business initiatives are always informed and strategically positioned for success. 

Start exploring thousands of trials today at trialinsights.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies

tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies

HealthEconomics.com